Nerventra
Teva considers up to 27 plant closures
May 13, 2014Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics
Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …
Teva’s Great White Hope knocked back by Europe
January 27, 2014Sales and Marketing CHMP, EU, MS, Nerventra, Teva
The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
